Some financial businesses become more valuable every time another dollar enters their ecosystem. More accounts create service revenue, larger balances create custodial income, and higher spending creates transaction fees.
That flywheel is getting stronger here, while profitability is rising much faster than the headline growth rate suggests.
AI warning (Sponsored)
Artificial intelligence is creating enormous opportunities—but some investors are also preparing for a very different future.
One veteran market analyst believes the next wave of AI could dramatically reshape the economy, and he's released a free briefing outlining the trends he's watching and the strategy he believes investors should understand.
Watch the Free Briefing.
What Just Happened
Another quarter brought new records
HealthEquity, Inc. (NASDAQ: HQY) reported fiscal second-quarter revenue of $350.7 million, up 8% year over year.
Net income increased 10% to $65.6 million, while non-GAAP EPS rose 15% to $1.24.
The standout number was adjusted EBITDA.
It increased 11% to $167 million, while adjusted EBITDA margin reached a record 48%, up from 46% last year.
That is an impressive profitability level for a company still growing accounts and assets at healthy rates.
Management responded by raising full-year guidance.
Fiscal 2027 revenue is now expected between $1.411 billion and $1.421 billion. Adjusted EBITDA should reach $628 million to $636 million, while non-GAAP EPS is expected between $4.66 and $4.73.
The market wanted even more
Despite the beat and guidance increase, the shares initially dropped more than 10% following the report.
The problem was expectations.
Wall Street had already moved estimates higher before earnings, so the guidance raise was closer to what the market anticipated than some hoped.
That gives you an interesting setup.
The business did not suddenly weaken. Accounts hit records, assets hit records, margins hit records, and management raised its outlook.
Expectations simply got ahead of the quarter.
The HSA Flywheel Keeps Growing
More than 10 million accounts are now on the platform
HealthEquity finished July with 10.7 million health savings accounts, up 8% from a year earlier.
New HSAs from sales increased 24% to 202,000 during the quarter.
Total accounts across HSAs and other consumer-directed benefits reached approximately 17.8 million.
The appeal of the model starts with the structure of an HSA.
People can use these accounts to save and pay for qualified healthcare expenses while receiving significant tax advantages.
Unlike a flexible spending account, HSA balances can generally remain in the account from year to year.
That encourages customers to accumulate assets rather than simply spend every dollar before a deadline.
For HealthEquity, every additional account creates another long-term relationship that can generate service, custodial, and transaction revenue.
John Templeton is one of the greatest investors of the 20th century — famous for buying cheap stocks globally before "international diversification" was a concept. He also made a famous personal financial decision that was explicitly about taxes. What was
- Templeton renounced his U.S. citizenship in 1964, moving to the Bahamas and converting to Bahamian citizenship — motivated primarily by reducing his tax burden as his wealth grew
- Templeton moved to the Bahamas from the U.S. in 1968, becoming a British subject shortly after. He was explicit that reducing U.S. taxes on his growing fortune was the primary motivation.
- Templeton set up his funds in the Cayman Islands in 1960, one of the first major fund managers to use offshore structures for tax efficiency
- Templeton moved his family to Canada in 1955, where he lived for 13 years before eventually relocating to the Bahamas
A-Rated AI Opportunity (Sponsored)
Louis Navellier says his $9 million Stock Grader system is flashing its highest rating on one AI stock for 2026.
This company recently reported record annual revenue of $113.5 billion, earned an A-rating in his system, and is tied to a major AI expansion linked to Elon Musk’s “Project Apex.”
Navellier says this is the same system that helped him spot Nvidia long before its historic run.
Now, he is revealing the name, ticker, and full analysis of his #1 AI stock pick for 2026, completely free.
Click here to get Louis Navellier’s #1 AI stock for 2026 before this free briefing comes down.
Nearly $38 Billion Is Sitting On The Platform
Assets grew faster than accounts
Total HSA assets increased 14% to $37.9 billion.
That growth rate is almost twice the increase in the number of HSAs.
This is important because HealthEquity's economics improve when existing members build larger balances.
The total included $17.4 billion of cash and $20.6 billion of investments.
Investment assets increased 28% year over year.
The number of HSAs containing investments also increased 20% to approximately 939,000.
That tells you members are increasingly using these accounts as long-term savings vehicles rather than simply checking accounts for medical bills.
The deeper the relationship becomes, the more difficult it can be for a customer to move elsewhere.
Investments can extend the lifetime value
A member with only a small cash balance may interact with the platform occasionally.
Someone who accumulates thousands of dollars and begins investing those funds has a very different relationship.
The account starts looking more like part of a long-term financial plan.
That can improve retention and give HealthEquity more opportunities to provide additional tools and services.
And there is still considerable room for penetration.
Fewer than one million of the company's 10.7 million HSAs currently contain investments.
You do not need every member to become an active investor for that number to grow substantially over time.
Elite Trade Club Insider
A Director Bought $6.55 Million Just After A $17 Billion Deal
You’re looking at one company making the biggest acquisition in its history and another marketplace finally showing signs of renewed growth. Elite Trade Club Insider readers are seeing what happened underneath those stories: one director voluntarily put $6.55 million into the stock immediately after a massive strategic bet, while three insiders at another company sold roughly $3 million through transactions that were largely decided months ago.
You’re reading the free version. Here’s what we held back.
Every day, insiders and institutions move millions before the market catches on. We surface the data behind those moves before the rest of the market sees it.
A subscription gets you:
The insider buys, options bets, and dark pool moves the free edition can't show you. Unlocked every weekday.
A Sunday Deep Dive that tells you where to look before Monday's bell rings.
The Friday Smart Money Brief: who bought, who sold, where the big options bets landed, and where institutions are hiding volume. Three data layers. One email.
A Monthly Insider Scorecard so you always know whether smart money is buying or selling the market.
Every past Insider edition, unlocked, on elitetrade.club. Go back and see what you missed.
$25/mo or $250/yr. 30-day money back guarantee. Cancel anytime. Founding member pricing: lock in $25/mo before we raise it.
Three Revenue Streams Make The Model Stronger
Custodial income is currently the biggest piece
HealthEquity generated $175.9 million of custodial revenue during Q2.
This revenue comes largely from the cash balances held through banking and insurance partners.
Service revenue contributed another $124.4 million, while interchange revenue added $50.4 million.
That gives you three different earnings drivers.
Service revenue benefits from having more accounts.
Custodial revenue benefits from larger cash balances and the yields earned on those balances.
Interchange revenue benefits when members actually use their accounts to pay healthcare expenses.
Together, they make the business more resilient than relying on a simple monthly subscription fee.
Sector Incentive Stocks (Sponsored)
For the first time ever, 25-year Buffett mentee Whitney Tilson is revealing the secretive project the Oracle of Omaha handed over to his successor at Berkshire Hathaway...
A niche "AI power" opportunity that Berkshire's new CEO is fully exploiting... and one Whitney believes could hand early investors a shot at America's next great energy fortune before a new power plant goes live this year.
The deadline to take advantage is approaching fast.
Click here to watch the "Project Vulcan" story for full details...
*This ad is sent on behalf of Stansberry Research, 1125 N Charles St, Baltimore, MD 21201. If you would like to optout from receiving offers from Stansberry Research please click here.
Higher Rates Have Helped, But There Is A Catch
Custodial yields matter
The $17.4 billion of HSA cash is extremely valuable to the business.
HealthEquity places much of that money with partner institutions and earns custodial revenue based partly on negotiated yields.
Higher interest rates have therefore supported profitability.
That also creates one of the biggest risks.
If rates fall significantly, the yields available when those balances reprice could eventually come down.
HealthEquity has some protection because much of its cash is locked into longer-term arrangements.
Roughly $16.7 billion of HSA cash covered by fixed-rate contracts carried an average annualized yield around 3.9% at the end of July.
A large portion does not reprice for several years.
That means lower rates would not immediately crush custodial revenue, but the direction of interest rates remains something you need to watch.
Margins Are Becoming The Bigger Story
Technology is helping the business scale
An 8% revenue increase produced an 11% increase in adjusted EBITDA and a 15% increase in non-GAAP EPS.
That tells you incremental growth is becoming more profitable.
Management has been emphasizing technology-enabled efficiencies across the platform, including efforts to simplify service and administration.
That matters in a business managing almost 18 million total accounts.
If technology allows each employee to service more members, the company can keep adding accounts without matching that growth dollar-for-dollar with operating expenses.
The record 48% adjusted EBITDA margin suggests that operating leverage is already showing up.
This is one reason the stock does not require explosive revenue growth to compound earnings.
Mid-single-digit to high-single-digit sales growth can still produce double-digit per-share growth when margins improve and the share count declines.
The Buyback Is Becoming Significant
More than $230 million spent in six months
HealthEquity repurchased approximately 1.2 million shares for $108.1 million during Q2.
Through the first half, buybacks totaled roughly $231 million.
And management still had approximately $948 million remaining under its authorization at the end of July.
That is substantial for a company valued around $8 billion before this edition was written.
The buyback can become another important part of the earnings algorithm.
If HealthEquity continues growing net income while reducing the share count, EPS can rise faster than total profits.
The company generated approximately $234 million of operating cash flow during the first half, up from $201 million a year earlier.
That supports the capital-return story, although HealthEquity also carries roughly $931 million of long-term debt.
Management still needs to balance repurchases against debt reduction and continued investment in the platform.
Why The Pullback Has A Case
The earnings reaction looks more like a reset in expectations than a deterioration in the business.
You still have:
10.7 million HSAs.
Nearly $38 billion of HSA assets.
24% growth in new accounts sold during the quarter.
28% growth in invested HSA assets.
A record 48% adjusted EBITDA margin.
Higher full-year guidance.
And almost $1 billion of remaining buyback authorization.
Those are not the numbers you normally associate with a broken growth story.
The question is whether management can keep expanding accounts while protecting custodial economics if interest rates eventually move lower.
What Could Trip It Up
Lower interest rates could pressure custodial revenue
The effect would take time because of the company's longer-duration agreements, but lower reinvestment yields would eventually create a headwind.
Account growth needs to continue
The platform becomes more valuable as new HSAs arrive. A meaningful slowdown in employer or health-plan wins would weaken the long-term growth rate.
Regulation matters
HSAs exist within U.S. tax and healthcare policy. Changes to contribution rules, eligibility, or tax treatment could affect industry growth.
The balance sheet still has debt
Aggressive buybacks look attractive when cash flow is strong, but nearly $1 billion of long-term debt means management cannot treat every available dollar as excess capital.
My Take
Buy on pullbacks. HealthEquity gives you a scalable financial platform with record accounts, growing assets, multiple revenue streams, expanding margins, and an increasingly powerful buyback program. The initial earnings selloff appears driven more by elevated expectations than worsening fundamentals.
The key risk is interest-rate sensitivity. Custodial revenue is a major part of the business, and lower rates can eventually pressure yields earned on HSA cash. The long maturity structure provides a buffer, but you should watch that revenue stream closely as the rate cycle changes.
Action Recap
🏥 Looking to buy? Buy on pullbacks. The earnings reset gives you a better entry into a business still setting operating records.
📈 Already own it? Keep holding while HSA accounts, invested assets, and adjusted EBITDA margins continue rising.
⚠️ Main risk to respect: Falling interest rates could eventually reduce the economics of the billions in HSA cash sitting on the platform.
You Read This Far. Here's Where the Real Work Lives.
We run three live portfolios on Autopilot, and everything about them is public: every position, every allocation, every trade, visible the moment it happens.
We keep our own money in each one, because analysis you won't fund yourself is just content.
THE UNBREAKABLE STACK
Our growth book: durable software and cybersecurity names built to compound quietly for years.
THE HORMUZ PREMIUM
Our energy thesis: built for how that sector actually pays, over quarters, not headlines.
THE SQUEEZE
The defensive sleeve: staples and steady compounders, boring on purpose, built for the nights you'd rather sleep than watch futures.
And here's the part that makes it effortless: Autopilot does the trading for you. Connect the brokerage you already use (Robinhood, Schwab, Fidelity, and more) and every move we make gets mirrored in your own account automatically.
Your money never leaves your brokerage. It stays in your account, under your control, and you can override any trade or disconnect anytime. Autopilot even rebalances automatically when allocations drift, and you get a notification every time something happens.
No watching tickers. No timing entries. No fat-finger mistakes at market open. You pick the portfolio, we do the work, your account follows along.
Pick the one that fits your risk level, or run all three:
Live portfolios, real positions, our own capital at stake. Your funds stay in your own brokerage account. Past performance doesn't guarantee future results.
That’s all for today. Thank you for reading. If you have any feedback, please reply to this email.
Best Regards,
— Adam Garcia
Elite Trade Club
Click here to get our daily newsletter straight to your cell for free.
P.S. Just like this newsletter, it's 100% free*, and you can stop at any time by replying STOP.
